Panel recommends Serum Institute's name for phase 2, 3 human clinical trials of Oxford vaccine candidate
Posted by
www.biotecnika.org
The recommendations of the committee at the Central Drugs Standard
Control Organisation have been sent to the Drugs Controller General of
India for approval.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-recommends-serum-institutes-name-for-phase-2-3-human-clinical-trials-of-oxford-vaccine-candidate/articleshow/77287839.cms
Subscribe to:
Post Comments (Atom)
Post a Comment